Претраживање
Приказ резултата 1-10 од 21
Dual Inhibitors as a New Challenge for Cancer Multidrug Resistance Treatment.
(Current Medicinal Chemistry, 2019)
Potential of Natural-Based Anticancer Compounds for P-Glycoprotein Inhibition.
(Current Pharmaceutical Design, 2018)
Uspostavljanje rezistentnih tumorskih ćelijskih linija kao modela za testiranje novih hemioterapeutika: molekularna karakterizacija rezistencije nastale dugotrajnim izlaganjem paklitakselu / The establishing of resistant cancer cell lines as a model for testing of new chemotherapeutics: molecular characterization of resistance developed after continuous treatment with paclitaxel
(Belgrade: University of Belgrade, Faculty of Belgrade, 2013)
Dual Inhibitors as a New Challenge for Cancer Multidrug Resistance Treatment
(Sharjah: Bentham Science Publishers, 2019)
Multi-drug Resistance in Cancer and New Approaches for Its Overcoming
(New York : Nova Science Publishers, Inc., 2014)
Potential of Natural-Based Anticancer Compounds for P-Glycoprotein Inhibition
(Sharjah: Bentham Science Publishers, 2018)
DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells
(European Journal of Pharmaceutical Sciences, 2017)
New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer
(Sharjah: Bentham Science Publishers, 2015)
Two new jatrophane diterpenes from the roots of Euphorbia nicaeensis
(Belgrade : Serbian Chemical Society, 2021)